Cytek Biosciences, Inc. (CTKB) — 8-K Filings

8-K Filings (15)

• Cytek Biosciences Files 8-K on Financials — Nov 5, 2025 Risk: low
  Cytek Biosciences, Inc. filed an 8-K on November 5, 2025, reporting on its results of operations and financial condition. The filing includes financial statemen
• Cytek Biosciences Files 8-K for Operations Update — Aug 6, 2025 Risk: low
  Cytek Biosciences, Inc. filed an 8-K on August 6, 2025, to report on its results of operations and financial condition, as well as to file financial statements
• Cytek Biosciences Files 8-K on Security Holder Vote Matters — Jun 24, 2025 Risk: low
  On June 18, 2025, Cytek Biosciences, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing does not specify
• Cytek Biosciences Files 8-K on Financials — May 8, 2025 Risk: low
  Cytek Biosciences, Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition. The filing includes financial statements an
• Cytek Biosciences Files 8-K on Financials — Feb 27, 2025 Risk: low
  On February 27, 2025, Cytek Biosciences, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as
• Cytek Biosciences Files 8-K on Financials — Jan 15, 2025 Risk: low
  Cytek Biosciences, Inc. filed an 8-K on January 15, 2025, reporting on its results of operations and financial condition. The filing includes financial statemen
• Cytek Biosciences Files 8-K on Financials — Nov 5, 2024 Risk: low
  Cytek Biosciences, Inc. filed an 8-K on November 5, 2024, reporting on its results of operations and financial condition. The filing includes financial statemen
• Cytek Biosciences Announces Executive and Board Changes — Sep 12, 2024 Risk: medium
  Cytek Biosciences, Inc. announced on September 9, 2024, changes in its executive team and board of directors. Specifically, Dr. John W. King has been appointed
• Cytek Biosciences Files 8-K on Financials — Aug 6, 2024 Risk: low
  Cytek Biosciences, Inc. filed an 8-K on August 6, 2024, to report on its results of operations and financial condition. The filing provides updated financial st
• Cytek Biosciences Files 8-K on Shareholder Vote Matters — Jun 11, 2024 Risk: low
  Cytek Biosciences, Inc. filed an 8-K on June 11, 2024, reporting on matters submitted to a vote of security holders on June 5, 2024. The filing details the comp
• Cytek Biosciences Files 8-K for Financial Reporting — May 8, 2024 Risk: low
  Cytek Biosciences, Inc. filed an 8-K on May 8, 2024, to report on its results of operations and financial condition, as well as to file financial statements and
• Cytek Biosciences Appoints New Director, Reports Officer Compensation — Mar 19, 2024 Risk: low
  Cytek Biosciences, Inc. announced on March 17, 2024, the departure of Director Dr. Robert J. Massoud and the appointment of Dr. David J. Ebersole as a new direc
• Cytek Biosciences Files 8-K on Financials — Mar 1, 2024 Risk: low
  Cytek Biosciences, Inc. filed an 8-K on March 1, 2024, reporting results of operations and financial condition as of February 28, 2024. The filing details finan
• Cytek Biosciences Reports Officer/Director Changes — Feb 27, 2024 Risk: medium
  Cytek Biosciences, Inc. filed an 8-K on February 27, 2024, reporting events that occurred on February 20, 2024. The filing indicates changes related to the depa
• Cytek Biosciences Files 8-K on Financial Condition & Results — Jan 9, 2024
  Cytek Biosciences, Inc. filed an 8-K on January 9, 2024, reporting an event that occurred on January 8, 2024, related to 'Results of Operations and Financial Co

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX